Medical device company wins award for cutting-edge drugs inhalation tech | FutureScot @NebuFlow @PhysicsNews @Futurescot_News https://t.co/Ibe6W7PYPo
🎉 Congratulations to @NebuFlow on receiving a Business Start-Up Award from the Institute of Physics @PhysicsNews for their innovation in respiratory drug delivery.
Incredibly well-deserved! Proud to support @NebuFlow through our #ImpactFirst fund.
https://t.co/PBc5HHAq85
Congratulations to Scottish MedTech innovators @NebuFlow 👏
“At Nebu~Flow, we are proud to lead the charge in reshaping the future of inhalation drug delivery to treat respiratory disorders,” - Chairman, Dr John Pritchard.
#ScotlandIsNow#Innovation
https://t.co/YYQlOPQwXU
The @NebuFlow team have had a busy few days at the Drug Delivery to the Lungs conference in Edinburgh. We had the opportunity to present our poster, listen to some fascinating talks and meet experts in the field from all across the globe. Until next year DDL! @DDLConferences
Our very own CEO, Elijah Nazarzadeh, and Chairman, John Pritchard have been published in the latest @ondrugdelivery Issue #140. Their article describes our novel approach to nebulisation for efficient delivery of drugs to the lungs.
Read more here 👉 https://t.co/HnDhw1D9b1
Happy Birthday @NebuFlow! This month we’ve been celebrating 2 years of the company. We have grown a lot over the years, expanding our team and continuing the development of our nebuliser. Over the coming weeks, we’ll introduce the Nebu~Flow team on our social media. Stay tuned!
A @UofGlasgow spin-out which aims to create more effective methods of treating lung diseases has secured a £1m grant from @innovateuk https://t.co/55qEO7r7zK
🫁 @UofGlasgow spinout @NebuFlow have received £1m investment to create more effective methods of treating lung diseases
It will advance their nebuliser technology which provides key advantages over existing solutions
👇 Read more
https://t.co/4CtDoJngCq
#Glasgow#Scotland
An investment of £1m from @innovateuk will help @NebuFlow, a spinout from @UofGEngineering, further develop Acu-Flow, their device which provides more effective methods of treating lung diseases.
Read more ➡️ https://t.co/R697PUxN5z
This £1m investment from @innovateuk into @UofGlasgow spinout @NebuFlow will help them bring their pioneering technology to market & ultimately help to create more effective methods of treating lung diseases👇
https://t.co/qh088VjTCb
Investment Announcement⚡️
Excited to support @NebuFlow@ElijaNazar & team in their recent £1.7m raise 🥁
Nebu-Flow is building next-gen #nebulisers to enable delivery of life changing treatments to people who need them most 🙌
https://t.co/IUVXVfMjgo
we are pleased to close £1.7m of investment funding to continue the commercialisation and delivery of next generation respiratory pharmaceuticals with the support of @ForesightGroup@WilliamsAdvEng @AscensionGrp @ScienceCreates and @socinvestscot
https://t.co/QX522WCXhU
We are looking for high calibre Engineers and Scientists to join our team based in Glasgow working on the next generation of nebulisers for respiratory drug delivery.
Visit our website https://t.co/ydyPrnGnxN to learn more!
@UKFluidsNetwork@UofGlasgow
Discover Beta Bugs (https://t.co/PZpD2x0vOv) and @NebuFlow in our next two pitches at EIE21!
Don't forget to rate this afternoon's pitches and let us know your thoughts by replying.
#MedTech#DigitalHealth#EIE21#MoreThanaDay